End Cash: The amount of cash held by the company for the given period.
Castle Biosciences, Inc. (CSTL) had End Cash of $77.99M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$102.89M |
|
$-4.10M |
|
$23.92M |
|
$78.97M |
|
$105.62M |
|
$-2.73M |
|
$-1.07M |
|
$-3.80M |
|
$-3.80M |
|
$-4.10M |
|
$-4.10M |
|
$-4.10M |
|
$-4.10M |
|
$-2.73M |
|
$1.10M |
|
30.63M |
|
30.63M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$356.86M |
|
$111.46M |
|
$222.55M |
|
$579.41M |
|
$67.61M |
|
$6.15M |
|
$33.35M |
|
$100.96M |
|
$478.44M |
|
$386.95M |
|
$478.44M |
|
30.77M |
|
| Cash Flow Statement Financials | |
$12.81M |
|
$-46.49M |
|
$-5.05M |
|
$116.73M |
|
|
End Cash |
$77.99M |
$-38.73M |
|
$32.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.28 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
76.75% |
|
-2.65% |
|
-2.65% |
|
-- |
|
-3.70% |
|
-3.98% |
|
$-15.76M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
2.30 |
|
1.97 |
|
45.57 |
|
-0.86% |
|
-1.06% |
|
-0.71% |
|
-0.85% |
|
$15.55 |
|
$-0.51 |
|
$0.42 |
|